AlphaTON Capital Corp — Director's Dealing 2018

Jan 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Biohaven Pharmaceutical Holding Co Ltd. (BHVN)
CIK: 0001689813
Period of Report: 2018-01-03

Reporting Person: PORTAGE BIOTECH INC. (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-01-04	Common Stock	S	4350	$28.6217	Disposed	124371.02	Direct